NCT02389101View on ClinicalTrials.gov

Molecular and Whole-body MR Imaging in Lymphomas

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

September 30, 2016

Conditions
LymphomaHodgkin DiseaseLymphoma, Non-Hodgkin
Interventions
OTHER

68Ga-DOTANOC PET/CT; Diffusion weighted MRI

PET/CT: Radionuclide imaging using short-lived isotope Ga-68; MRI imaging w/o gadolinium contrast

Trial Locations (1)

20521

Turku University Hospital, Turku

All Listed Sponsors
lead

Turku University Hospital

OTHER_GOV

NCT02389101 - Molecular and Whole-body MR Imaging in Lymphomas | Biotech Hunter | Biotech Hunter